Last 7 days
-6.4%
Last 30 days
-4.9%
Last 90 days
6.1%
Trailing 12 Months
25.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 73.0B | 60.9B | -4.91% | 25.24% | 12.73 | 1.2 | 1.94% | -15.77% |
LH | 20.7B | 14.8B | -2.77% | -13.32% | 16.22 | 1.39 | -6.96% | -52.35% |
DGX | 15.0B | 9.6B | -8.90% | -4.59% | 18.89 | 1.56 | -10.08% | -57.84% |
MID-CAP | ||||||||
UHS | 9.9B | 13.6B | -10.37% | 3.84% | 14.64 | 0.74 | 5.04% | -26.87% |
DVA | 8.5B | 11.7B | 9.28% | -3.24% | 16.63 | 0.73 | 0.42% | -43.11% |
THC | 7.2B | 19.4B | -1.91% | 7.28% | 7.07 | 0.37 | 0.01% | -33.70% |
EHC | 6.1B | 4.4B | -5.92% | 18.26% | 22.47 | 1.4 | 8.15% | -30.89% |
SGRY | 4.5B | 2.6B | -10.50% | -11.04% | -48.8 | 1.71 | 13.01% | -143.24% |
SEM | 3.4B | 6.4B | -7.51% | 11.50% | 19.08 | 0.54 | 2.26% | -46.98% |
SMALL-CAP | ||||||||
RDNT | 1.7B | 1.5B | 6.01% | 44.82% | -126.07 | 1.14 | 10.24% | -173.11% |
ADUS | 1.4B | 976.1M | -21.09% | 3.91% | 28.65 | 1.47 | 10.19% | 12.37% |
BKD | 645.6M | 2.9B | -18.53% | -39.08% | -3.53 | 0.22 | 7.97% | -101.02% |
CYH | 419.8M | 12.2B | -47.61% | -42.62% | -104.96 | 0.03 | -2.06% | -101.36% |
SSY | 6.7M | 46.8M | -7.74% | -13.61% | -2.44 | 0.14 | 12.07% | -154.21% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 1.1% | 60,879 | 60,233 | 59,800 | 60,105 | 59,720 |
EBITDA | 6.3% | 13,290 | 12,497 | 13,869 | 14,152 | - |
EBITDA Margin | 5.6% | 0.22* | 0.21* | 0.23* | 0.24* | - |
Earnings Before Taxes | 1.3% | 8,688 | 8,580 | 7,864 | 9,317 | 9,674 |
EBT Margin | 8.3% | 0.14* | 0.13* | 0.16* | 0.16* | - |
Interest Expenses | 4.1% | 1,812 | 1,741 | 1,686 | 1,638 | 1,590 |
Net Income | 1.6% | 5,733 | 5,643 | 5,376 | 6,511 | 6,806 |
Net Income Margin | 4.2% | 0.09* | 0.09* | 0.11* | 0.11* | - |
Free Cahsflow | -1.1% | 4,127 | 4,174 | 3,673 | 4,532 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | 0.5% | 52,711 | 52,438 | 51,484 | 51,584 | 52,208 |
Current Assets | -0.7% | 13,541 | 13,643 | 13,481 | 13,937 | 15,006 |
Cash Equivalents | -7.3% | 842 | 908 | 999 | 858 | 2,371 |
Inventory | 0.8% | 2,085 | 2,068 | 2,009 | 2,043 | 2,003 |
Net PPE | 1.9% | 26,053 | 25,575 | 24,978 | 24,587 | 24,228 |
Current Liabilities | 11.4% | 11,028 | 9,902 | 9,784 | 8,999 | 10,518 |
Long Term Debt | -3.1% | 37,710 | 38,903 | 37,696 | - | - |
LT Debt, Current | 542.7% | 2,378 | 370 | 218 | 246 | 1,486 |
LT Debt, Non Current | -3.3% | 36,478 | 37,714 | 37,492 | 38,657 | 36,210 |
Shareholder's Equity | 417.8% | 232 | -73.00 | -778 | -1,142 | 414 |
Retained Earnings | 11.1% | -2,028 | -2,280 | -2,781 | -3,168 | -1,589 |
Accumulated Depreciation | 0.8% | 29,410 | 29,182 | 28,752 | 28,229 | 27,814 |
Shares Outstanding | -0.5% | 276 | 277 | 284 | 287 | 302 |
Minority Interest | 1.2% | 2,727 | 2,694 | 2,592 | 2,538 | 2,447 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 5.4% | 8,980 | 8,522 | 8,438 | 7,695 | 8,316 |
Share Based Compensation | -2.6% | 332 | 341 | 357 | 385 | 429 |
Cashflow From Investing | -9.0% | -3,695 | -3,389 | -4,310 | -3,124 | -2,839 |
Cashflow From Financing | -20.3% | -6,806 | -5,656 | -4,124 | -4,810 | -4,126 |
Dividend Payments | -0.3% | 651 | 653 | 645 | 636 | 632 |
Buy Backs | -17.9% | 5,745 | 7,000 | 7,553 | 9,184 | 8,789 |
46.5%
36.1%
18.5%
Y-axis is the maximum loss one would have experienced if HCA Healthcare was unfortunately bought at previous high price.
21.8%
19.9%
21.6%
35.1%
FIve years rolling returns for HCA Healthcare.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-24 | Old North State Trust, LLC | unchanged | - | 5,000 | 57,000 | 0.04% |
2023-05-23 | Seaport Global Advisors, LLC | unchanged | - | 45,779 | 508,902 | 1.61% |
2023-05-23 | Toroso Investments, LLC | added | 280 | 5,225,000 | 6,866,000 | 0.12% |
2023-05-23 | Brookfield Corp /ON/ | new | - | 624,131 | 624,131 | -% |
2023-05-22 | Raleigh Capital Management Inc. | new | - | 3,700 | 3,700 | -% |
2023-05-22 | PUTNAM INVESTMENTS LLC | reduced | -6.91 | 3,981,020 | 177,447,000 | 0.28% |
2023-05-22 | American Trust | added | 7.05 | 54,594 | 364,142 | 0.03% |
2023-05-22 | Arete Wealth Advisors, LLC | added | 46.63 | -308,810,000 | 498,000 | 0.04% |
2023-05-22 | AMERIPRISE FINANCIAL INC | added | 5.54 | 11,845,200 | 85,826,200 | 0.03% |
2023-05-22 | FDx Advisors, Inc. | unchanged | - | - | 298,000 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | frist thomas f jr | 24.5% | 69,391,032 | SC 13G/A | |
Feb 14, 2023 | price t rowe associates inc /md/ | 2.5% | 7,039,050 | SC 13G/A | |
Feb 14, 2023 | hercules holding ii | 24.4% | 68,912,077 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 6.35% | 17,946,718 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 5.08% | 14,369,349 | SC 13G | |
Feb 01, 2023 | blackrock inc. | 5.2% | 14,839,215 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 6.7% | 21,128,934 | SC 13G/A | |
Feb 14, 2022 | hercules holding ii | 22.2% | 68,912,077 | SC 13G/A | |
Feb 14, 2022 | frist thomas f jr | 22.3% | 69,301,932 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 6.09% | 18,931,643 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 234.66 -11.25% | 319.32 20.77% | 422.14 59.65% | 532.64 101.44% | 621.73 135.14% |
Current Inflation | 215.81 -18.38% | 288.33 9.05% | 374.19 41.52% | 466.41 76.40% | 540.56 104.44% |
Very High Inflation | 192.42 -27.23% | 250.86 -5.12% | 317.59 20.11% | 389.42 47.28% | 447.00 69.06% |
Date Filed | Form Type | Document | |
---|---|---|---|
May 26, 2023 | 8-K | Current Report | |
May 16, 2023 | 4 | Insider Trading | |
May 08, 2023 | 4 | Insider Trading | |
May 04, 2023 | 8-K | Current Report | |
May 03, 2023 | 424B5 | Prospectus Filed | |
May 02, 2023 | 4 | Insider Trading | |
May 02, 2023 | 4 | Insider Trading | |
May 02, 2023 | 4 | Insider Trading | |
May 02, 2023 | 8-K | Current Report | |
May 01, 2023 | 424B3 | Prospectus Filed |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-05-12 | Hammett Richard A | gifted | - | - | -1,100 | group president |
2023-05-04 | HAZEN SAMUEL N | gifted | - | - | 7,864 | ceo |
2023-05-04 | HAZEN SAMUEL N | gifted | - | - | 4,647 | ceo |
2023-05-04 | HAZEN SAMUEL N | gifted | - | - | -12,511 | ceo |
2023-05-01 | Akdamar Erol R | gifted | - | - | -42,484 | group president |
2023-05-01 | Akdamar Erol R | gifted | - | - | 42,484 | group president |
2023-04-28 | Torres Kathryn A. | acquired | 1,251,530 | 141 | 8,844 | svp-payer contracting & align. |
2023-04-28 | Cuffe Michael S. | sold | -3,571,400 | 284 | -12,556 | evp and chief clinical officer |
2023-04-28 | Torres Kathryn A. | sold (taxes) | -1,759,320 | 287 | -6,123 | svp-payer contracting & align. |
2023-04-28 | Akdamar Erol R | sold | -997,500 | 285 | -3,500 | group president |
Condensed Consolidated Income Statements (Unaudited) - USD ($) shares in Thousands, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Revenues | $ 15,591 | $ 14,945 |
Salaries and benefits | 7,084 | 6,939 |
Supplies | 2,423 | 2,321 |
Other operating expenses | 2,894 | 2,752 |
Equity in losses (earnings) of affiliates | 18 | (11) |
Depreciation and amortization | 756 | 732 |
Interest expense | 479 | 408 |
Losses (gains) on sales of facilities | 15 | (10) |
Total expenses including equity in earnings of affiliates | 13,669 | 13,131 |
Income before income taxes | 1,922 | 1,814 |
Provision for income taxes | 379 | 349 |
Net income | 1,543 | 1,465 |
Net income attributable to noncontrolling interests | 180 | 192 |
Net income attributable to HCA Healthcare, Inc. | $ 1,363 | $ 1,273 |
Per share data: | ||
Basic earnings | $ 4.92 | $ 4.21 |
Diluted earnings | $ 4.85 | $ 4.14 |
Shares used in earnings per share calculations (in millions): | ||
Basic | 276,910 | 302,446 |
Diluted | 280,961 | 307,374 |
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 842 | $ 908 |
Accounts receivable | 8,657 | 8,891 |
Inventories | 2,085 | 2,068 |
Other | 1,957 | 1,776 |
Total current assets | 13,541 | 13,643 |
Property and equipment, at cost | 55,463 | 54,757 |
Accumulated depreciation | (29,410) | (29,182) |
Property and equipment, net | 26,053 | 25,575 |
Investments of insurance subsidiaries | 390 | 381 |
Investments in and advances to affiliates | 786 | 823 |
Goodwill and other intangible assets | 9,590 | 9,653 |
Right-of-use operating lease assets | 2,032 | 2,065 |
Other | 319 | 298 |
Total assets | 52,711 | 52,438 |
Current liabilities: | ||
Accounts payable | 3,769 | 4,239 |
Accrued salaries | 1,565 | 1,712 |
Other accrued expenses | 3,316 | 3,581 |
Long-term debt due within one year | 2,378 | 370 |
Total current liabilities | 11,028 | 9,902 |
Long-term debt, less debt issuance costs and discounts of $295 and $301 | 36,478 | 37,714 |
Professional liability risks | 1,565 | 1,528 |
Right-of-use operating lease obligations | 1,716 | 1,752 |
Income taxes and other liabilities | 1,692 | 1,615 |
Stockholders equity (deficit): | ||
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 275,939,900 shares - 2023 and 277,378,300 shares - 2022 | 3 | 3 |
Accumulated other comprehensive loss | (470) | (490) |
Retained deficit | (2,028) | (2,280) |
Stockholders' deficit attributable to HCA Healthcare, Inc. | (2,495) | (2,767) |
Noncontrolling interests | 2,727 | 2,694 |
Total stockholders' equity | 232 | (73) |
Total liabilities and stockholders' equity | $ 52,711 | $ 52,438 |